CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies
Nobutaka Hanagata1,2 1Nanotechnology Innovation Station, National Institute for Materials Science, Tsukuba, Ibaraki, 2Graduate School of Life Science, Hokkaido University, Sapporo, Hokkaido, Japan Abstract: Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG ODNs), which...
Main Author: | Hanagata N |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2017-01-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/cpg-oligodeoxynucleotide-nanomedicines-for-the-prophylaxis-or-treatmen-peer-reviewed-article-IJN |
Similar Items
-
Incorporation of CpG Oligodeoxynucleotides into α2-Macroglobulin: Development of a Novel Vaccine Adjuvant Delivery Mechanism
by: Anderson, Ryan Berger
Published: (2007) -
Synthetic Human TLR9-LRR11 Peptide Attenuates TLR9 Signaling by Binding to and thus Decreasing Internalization of CpG Oligodeoxynucleotides
by: Xichun Pan, et al.
Published: (2016-02-01) -
Lipid Nanoparticles Potentiate CpG-Oligodeoxynucleotide-Based Vaccine for Influenza Virus
by: Seiki Shirai, et al.
Published: (2020-01-01) -
Topical CpG Oligodeoxynucleotide Adjuvant Enhances the Adaptive Immune Response Against Influenza A Infections
by: Wing Ki Cheng, et al.
Published: (2016-07-01) -
CpG plus radiotherapy: a review of preclinical works leading to clinical trial
by: Kathy A. Mason, et al.
Published: (2012-08-01)